New Vaccine Has the Potential To Treat Several Different Cancers

Article by Laura Elizabeth Lansdowne.

Researchers recently reported in Clinical & Translational Immunology the development of a novel cancer vaccine.

The vaccine is designed to target malignancies that express the transcription factor Wilms’ tumor 1 (WT1) – a well characterized and highly immunogenic tumor‐associated antigen. As WT1 is overexpressed in several hematological and solid malignancies, the vaccine has the potential to treat many different cancers.

Technology Networks had the pleasure of speaking with the project’s lead researcher,Associate ProfessorKristen Radford to learn more about the CLEC9A-WT1 vaccine, how it works and the key advantages it offers compared to existing cancer vaccines. […]

Click here to view original web page at www.technologynetworks.com